Literature DB >> 16741617

Farnesoid X receptor, hepatocyte nuclear factors 1alpha and 3beta are essential for transcriptional activation of the liver-specific organic anion transporter-2 gene.

Hideo Ohtsuka1, Takaaki Abe, Tohru Onogawa, Noriko Kondo, Takeaki Sato, Hiroshi Oshio, Hiroya Mizutamari, Tsuyoshi Mikkaichi, Masaya Oikawa, Toshiki Rikiyama, Yu Katayose, Michiaki Unno.   

Abstract

BACKGROUND: We isolated the human liver-specific organic anion transporter gene, LST-2 (OATP8/SLCO1B3), which is exclusively expressed in the basolateral membrane of the hepatocytes. In this study, we analyzed the transcriptional regulation of the LST-2 gene in hepatocyte-derived cells and the effect of bile acid.
METHODS: Transcriptional activity of the LST-2 gene was measured using a human LST-2 promoter-luciferase reporter plasmid under various concentrations of bile acids. Electrophoresis mobility shift assays of farnesoid X receptor (FXR), hepatocyte nuclear factor (HNF) 1alpha, and HNF3beta were performed.
RESULTS: Luciferase analysis showed that the 5'-flanking region from -180 to -20 bp is responsible for LST-2 transcriptional activity. By site-directed mutation analysis, it was revealed that the consensus binding sites for FXR, HNF1alpha, and HNF3beta play important roles in the transcriptional activity of the LST-2 gene. By electrophoresis mobility shift assay, we observed specific protein-DNA complexes of FXR, HNF1alpha, and HNF-3beta. Luciferase activity was increased fivefold when chenodeoxycholate or deoxycholate were added. Northern blot analyses revealed that the expression of LST-2 was increased by addition of chenodeoxycholate or deoxycholate in a dose-dependent manner.
CONCLUSIONS: This study demonstrated that the transcription of the LST-2 gene is regulated by three transcription factors, FXR, HNF1alpha, and HNF3beta. HNF1alpha and HNF3beta might contribute to its liver-specific expression, and FXR might play a role in its transcriptional activation by bile acids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741617     DOI: 10.1007/s00535-006-1784-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  24 in total

1.  Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1.

Authors:  M Kakyo; M Unno; T Tokui; R Nakagomi; T Nishio; H Iwasashi; D Nakai; M Seki; M Suzuki; T Naitoh; S Matsuno; H Yawo; T Abe
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

2.  Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1.

Authors:  T Abe; M Kakyo; T Tokui; R Nakagomi; T Nishio; D Nakai; H Nomura; M Unno; M Suzuki; T Naitoh; S Matsuno; H Yawo
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

3.  The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp.

Authors:  L A Denson; E Sturm; W Echevarria; T L Zimmerman; M Makishima; D J Mangelsdorf; S J Karpen
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

Review 4.  Liver-enriched transcription factors and hepatocyte differentiation.

Authors:  S Cereghini
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

5.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

Authors:  I Tamai; J Nezu; H Uchino; Y Sai; A Oku; M Shimane; A Tsuji
Journal:  Biochem Biophys Res Commun       Date:  2000-06-24       Impact factor: 3.575

6.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

Authors:  T Abe; M Unno; T Onogawa; T Tokui; T N Kondo; R Nakagomi; H Adachi; K Fujiwara; M Okabe; T Suzuki; K Nunoki; E Sato; M Kakyo; T Nishio; J Sugita; N Asano; M Tanemoto; M Seki; F Date; K Ono; Y Kondo; K Shiiba; M Suzuki; H Ohtani; T Shimosegawa; K Iinuma; H Nagura; S Ito; S Matsuno
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

7.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.

Authors:  H Wang; J Chen; K Hollister; L C Sowers; B M Forman
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

Review 8.  Liver enriched transcription factors and differentiation of hepatocellular carcinoma.

Authors:  Y Hayashi; W Wang; T Ninomiya; H Nagano; K Ohta; H Itoh
Journal:  Mol Pathol       Date:  1999-02

9.  A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.

Authors:  B Hsiang; Y Zhu; Z Wang; Y Wu; V Sasseville; W P Yang; T G Kirchgessner
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression.

Authors:  Diana Jung; Gerd A Kullak-Ublick
Journal:  Hepatology       Date:  2003-03       Impact factor: 17.425

View more
  12 in total

1.  The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin.

Authors:  Miao Hu; Sandra S H Lui; Lai-Shan Tam; Edmund K Li; Brian Tomlinson
Journal:  J Lipid Res       Date:  2012-04-24       Impact factor: 5.922

Review 2.  Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes.

Authors:  Barbara Bonamassa; Dexi Liu
Journal:  Adv Drug Deliv Rev       Date:  2010-08-14       Impact factor: 15.470

3.  DNA methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines.

Authors:  Sayaka Ichihara; Ryota Kikuchi; Hiroyuki Kusuhara; Satoki Imai; Kazuya Maeda; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2010-02-04       Impact factor: 4.200

4.  Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.

Authors:  Shiwei Zhou; Yan Shu
Journal:  Drug Metab Dispos       Date:  2022-05-29       Impact factor: 3.579

Review 5.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

6.  Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines.

Authors:  Hiroshi Oshio; Takaaki Abe; Tohru Onogawa; Hideo Ohtsuka; Takeaki Sato; Takayuki Ii; Kouji Fukase; Mitsuhisa Muto; Yu Katayose; Masaya Oikawa; Toshiki Rikiyama; Shinichi Egawa; Michiaki Unno
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

Review 7.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

8.  Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p.

Authors:  Roberto H Barbier; Edel M McCrea; Kristi Y Lee; Jonathan D Strope; Emily N Risdon; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.996

9.  Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.

Authors:  Veronika Buxhofer-Ausch; Lena Secky; Katrin Wlcek; Martin Svoboda; Valentinos Kounnis; Evangelos Briasoulis; Andreas G Tzakos; Walter Jaeger; Theresia Thalhammer
Journal:  J Drug Deliv       Date:  2013-02-03

10.  Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1.

Authors:  Anne T Nies; Mikko Niemi; Oliver Burk; Stefan Winter; Ulrich M Zanger; Bruno Stieger; Matthias Schwab; Elke Schaeffeler
Journal:  Genome Med       Date:  2013-01-11       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.